Renevo makes second attempt at floatation

The improving fortunes of the UK biotech industry were highlighted today when Renovo launched its second attempt to list on the stock market.

Renovo, which develops drugs that prevent and reduce scarring on the skin and inside the body, aims to raise £40m (€58m) by offering shares to institutional investors.